SCHEMBL24323828

SCHEMBL24323828

CNCCOc1cc(-c2c(C)cccc2C)nc(NSc2cccc(C(=O)O)c2)n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MITF O75030 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
PAX8 Q06710 1/20 0.33
KLF5 Q13887 1/20 0.33
APEX1 P27695 1/20 0.33
HTR1B P28222 1/20 0.33
SYK P43405 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24323158 0.89 KDM4E (0.35) SMN1; SMN2NPC1RAB9AKMT2AALDH1A1
SCHEMBL24298312 0.87 EGFR (0.36) CA12CA2CA9
SCHEMBL24326406 0.86 SYK (0.40) KMT2AALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL26846380 0.85 SCN4A (0.34) SMN1; SMN2NPC1RAB9AKMT2AALDH1A1
SCHEMBL26575341 0.82 NPC1 (0.32) SMN1; SMN2NPC1RAB9AKMT2AALDH1A1
SCHEMBL22509294 0.82 AAK1 (0.34) SMN1; SMN2NPC1RAB9AKMT2AALDH1A1
SCHEMBL24298810 0.82 AAK1 (0.34) SMN1; SMN2NPC1RAB9AKMT2AALDH1A1
SCHEMBL24299252 0.82 CYP1A2 (0.40) SMN1; SMN2CYP1A2CYP2C9HPGDHSD17B10
SCHEMBL24299050 0.82 LOXL2 (0.32) SMN1; SMN2NPC1RAB9AKMT2AALDH1A1
SCHEMBL24298126 0.81 SYK (0.32) SMN1; SMN2NPC1RAB9AKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076622-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed